INBX
Inhibrx Biosciences, Inc.
93.40$
-0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +789.7% | +0.0% | -9.2% | +209.9% | -85.8% | -20.6% | -66.4% | +226.6% | +282.3% | +74.7% | -52.4% | -68.9% | +10.5% | +165.4% | +12.0% | -67.7% | -22.3% | -60.9% | -1.4% | -93.8% | +76.5% | +296.7% | +1,273.1% | -100.0% | – | -100.0% | – | -100.0% | – | -100.0% | – | – | – | – | |
| – | +47.9% | -21.2% | -44.9% | +127.9% | +14.1% | -95.8% | -99.2% | – | – | +4.5% | – | – | +8.9% | -96.2% | +2.4% | +1.0% | +1.3% | +1.6% | +0.1% | -59.2% | +0.3% | +3.1% | -2.0% | +20.8% | +31.9% | +60.0% | -9.3% | -2.0% | -1.9% | -12.1% | -3.1% | -4.8% | – | – | |
| – | – | – | – | – | -87.2% | -73.9% | -8.7% | +231.6% | -1,893.6% | – | – | -661.1% | – | +94.5% | +15.5% | -89.9% | -98.6% | -14,800.0% | – | – | – | – | – | -126.9% | – | -860.0% | – | – | – | -191.2% | – | – | – | – | |
| – | +47.9% | -21.2% | -44.9% | +127.9% | +14.1% | +5.0% | -3.9% | +38.5% | +11.5% | +4.5% | -10.9% | -7.0% | +8.9% | +3.3% | +0.7% | +33.7% | +20.1% | -16.6% | +22.1% | +22.0% | -8.8% | +12.4% | +115.0% | -22.3% | +6.3% | -43.5% | -12.7% | +10.5% | -39.6% | +28.1% | -11.2% | -2.6% | -3.2% | – | |
| – | +3.5% | +8.6% | +69.0% | -12.2% | +11.5% | -9.5% | +199.4% | -66.9% | +4.4% | +5.9% | +36.6% | +35.8% | -5.2% | -0.2% | +28.0% | +38.6% | +6.9% | -1.0% | -0.4% | +20.2% | +13.5% | +8.6% | -0.7% | +27.3% | +836.1% | -91.5% | +110.8% | -63.8% | +6.6% | -17.8% | +5.6% | +2.4% | +44.5% | – | |
| – | +0.3% | +10.6% | +69.6% | -12.2% | +12.2% | +208.0% | +232.6% | +10.5% | +10.9% | +4.3% | -7.0% | -84.9% | +593.5% | -0.5% | +4.4% | +35.6% | +18.3% | -14.6% | +18.6% | +24.1% | -5.6% | +11.1% | +96.4% | -18.0% | +119.1% | -71.4% | +7.2% | -14.4% | -33.6% | +18.6% | -8.6% | +0.1% | +5.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -14.0% | – | – | +98.4% | +444.9% | -13.4% | +6.0% | +38.9% | +30.0% | -88.0% | +40.0% | +22.7% | +94.5% | +0.1% | +27.8% | +38.4% | +69.6% | +0.1% | -5.0% | +55.6% | +3.1% | +0.9% | -1.1% | -34.1% | -100.0% | – | – | +16.8% | +1.3% | +0.1% | +10.2% | +62.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -102.4% | – | – | – | – | – | – | – | – | |
| – | – | -1.4% | -90.9% | +463.0% | -100.8% | – | +157.0% | +6.4% | +38.2% | -85.7% | -99.4% | -33.3% | +45,850.0% | +93.4% | -117.3% | – | -99.8% | +132,950.0% | -100.0% | – | – | -60.0% | -300.0% | – | -99.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -102.4% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -102.3% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.